Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 22, 2011
Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis
Camilo de la Fuente-Sandoval, Pablo León-Ortiz, Rafael Favila, et al.
Plos One
|
April 21, 2010
Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life
Christina Ting, Tarek K Rajji, Zahinoor Ismail, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 31, 2014
Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO
Fernando Caravaggio, Shinichiro Nakajima, Carol Borlido, et al.
Biological Psychiatry
|
August 12, 2011
Exploring the neural correlates of delusions of reference
Mahesh Menon, Taylor W Schmitz, Adam K Anderson, et al.
Human Brain Mapping
|
May 15, 2007
Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans
Ariel Graff-Guerrero, Matthaeus Willeit, Nathalie Ginovart, et al.
Archives of General Psychiatry
|
June 3, 2009
The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO
Ariel Graff-Guerrero, David Mamo, C M Shammi, et al.
Psychopharmacology
|
February 19, 2013
Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study
Takefumi Suzuki, Ariel Graff-Guerrero, Hiroyuki Uchida, et al.
Psychopharmacology
|
June 4, 2008
The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist
Sridhar Natesan, Greg E Reckless, Karen B L Barlow, et al.
The Journal of Clinical Psychiatry
|
September 13, 2012
A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia
Saeko Ikai, Gary Remington, Takefumi Suzuki, et al.
British Journal of Clinical Pharmacology
|
February 3, 2022
MAP Bayesian modelling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patients
Mohamed Ismail, Thomas Straubinger, Hiroyuki Uchida, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 22, 2011
Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis
Camilo de la Fuente-Sandoval, Pablo León-Ortiz, Rafael Favila, et al.
Plos One
|
April 21, 2010
Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life
Christina Ting, Tarek K Rajji, Zahinoor Ismail, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 31, 2014
Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO
Fernando Caravaggio, Shinichiro Nakajima, Carol Borlido, et al.
Biological Psychiatry
|
August 12, 2011
Exploring the neural correlates of delusions of reference
Mahesh Menon, Taylor W Schmitz, Adam K Anderson, et al.
Human Brain Mapping
|
May 15, 2007
Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans
Ariel Graff-Guerrero, Matthaeus Willeit, Nathalie Ginovart, et al.
Archives of General Psychiatry
|
June 3, 2009
The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO
Ariel Graff-Guerrero, David Mamo, C M Shammi, et al.
Psychopharmacology
|
February 19, 2013
Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study
Takefumi Suzuki, Ariel Graff-Guerrero, Hiroyuki Uchida, et al.
Psychopharmacology
|
June 4, 2008
The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist
Sridhar Natesan, Greg E Reckless, Karen B L Barlow, et al.
The Journal of Clinical Psychiatry
|
September 13, 2012
A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia
Saeko Ikai, Gary Remington, Takefumi Suzuki, et al.
British Journal of Clinical Pharmacology
|
February 3, 2022
MAP Bayesian modelling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patients
Mohamed Ismail, Thomas Straubinger, Hiroyuki Uchida, et al.
Page
of 4